Cargando…

Diabetic Ketoacidosis With Alpelisib

Background: Hyperglycemia is a frequently reported adverse effect of alpelisib, an isoform specific phosphoinositide 3 kinase inhibitor, which is recently approved for use in hormone receptor positive advanced or metastatic breast cancer. Though two patients in clinical trials with alpelisib develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeun, Rebecca, Lavis, Victor Ralph, Thosani, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089606/
http://dx.doi.org/10.1210/jendso/bvab048.767